Sign in
CompletedNo phase

Seroprevalence and Risk Factors of H. Pylori Infection in Korea in 2023: Nationwide Multicenter Prospective Study

Key facts

Who runs it
Seoul National University Bundang Hospital
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
19,680 people enrolled
Started
1 Jul 2023
Ended
30 Jun 2024
Type of study
Observational, 3 groups
Record updated
13 November 2026

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Individuals undergoing routine health screening at 10 healthcare centers in South Korea between July 2023 and December 2024. The study included participants who underwent Helicobacter pylori serologic testing and gastrointestinal endoscopic examinations

Who cannot take part

  • History of colectomy
  • Inflammatory bowel disease
  • Gastric cancer or a history of gastrectomy for gastric cancer
  • Individuals without colonoscopy or esophagogastroduodenoscopy records

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Helicobacter pylori Infection in South Korea: Seroprevalence, Risk Factors, and Association with Colorectal Adenoma

The 3 groups in the trial

  • The never-exposed group

    negative IgG results and no prior eradication therapy

  • The eradicated group

    seronegative participants with a history of eradication therapy, participants with weakly positive IgG results were also classified into the eradicated group if a negative result was documented on an additional post-treatment confirmatory test, such as a urea breath test or rapid urease test, or if they reported during a structured interview that successful eradication had been confirmed after treatment

  • The seropositive group

    positive IgG titers who did not meet the criteria for the eradicated group

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Seroprevalence and Risk Factors of Helicobacter Pylori Infection in Korea in 2023 - Nationwide Multicenter Prospective Study -
Record updated
13 November 2026